#BEGIN_DRUGCARD DB04183

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
516-05-2

# ChEBI_ID:
30860

# Chemical_Formula:
C4H6O4

# Chemical_IUPAC_Name:
2-methylpropanedioic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
6.79E+005 mg/L (at 25 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Methylmalonic Acid

# HET_ID:
DXX

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H6O4/c1-2(3(5)6)4(7)8/h2H,1H3,(H,5,6)(H,7,8)

# InChI_Key:
InChIKey=ZIYVHBGGAOATLY-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C02170

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4183

# Mechanism_Of_Action:
Not Available

# Melting_Point:
135 dec °C

# Molecular_Weight_Avg:
118.088

# Molecular_Weight_Mono:
118.02660868

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1ON3

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.17

# Predicted_LogS:
0.1

# Predicted_Water_Solubility:
1.49e+02 g/l

# Primary_Accession_No:
DB04183

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
487

# PubChem_Substance_ID:
46506625

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01309

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(C(O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:04 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
3.12 (at 20 °C)

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
L04196

# Drug_Target_1_GenBank_ID_Protein:
150933

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>1818 bp
ATGGCTGAAAACAACAATTTGAAGCTCGCCAGCACCATGGAAGGTCGCGTGGAGCAGCTC
GCAGAGCAGCGCCAGGTGATCGAAGCCGGTGGCGGCGAACGTCTCGTCGAGAAGCAACAT
TCCCAGGGTAAGCAGACCGCTCGTGAGCGCCTGAACAACCTGCTCGATCCCCATTCGTTC
GACGAGGTCGGCGCTTTCCGCAAGCACCGCACCACGTTGTTCGGCATGGACAAGGCCGTC
GTCCCGGCAGATGGCGTGGTCACCGGCCGTGGCACCATCCTTGGTCGTCCCGTGCACGCC
GCGTCCCAGGACTTCACGGTCATGGGTGGTTCGGCTTGGCGAGACGCAGTCCACGAAGGT
CGTCGAGACGATGGAACAGCGCTGCTCACCGGCACGCCCTTCCTGTTCTTCTACGATTCG
GGCGGCCGGATCCAGGAGGGCATCGACTCGCTGAGCGGTTACGGCAAGATGTTCTTCGCC
AACGTGAAGCTGTCGGGCGTCGTGCCGCAGATCGCCATCATTGCCGGCCCCTGTGCGTGC
GCCTCGTATTCGCCGGCACTGACTGACTTCATCATCATGACCAAGAAGGCCCATATGTTC
ATCACGGGCCCCCAGGTCATCAAGTCGGTCACCGGCGAGGATGTCACCGCTGACGAACTC
GGTGGCGCTGAGCCCATATGGCCATCTCGGGCAATATACTTCGTGGCCGAGGACGACGAC
GCCGCGGAGCTCATTGCCAAGAAGCTGCTGAGCTTCCTTCCGCAGAACAACACTGAGGAA
GCATCCTTCGTCAACCCGAACAATGACGTCAGCCCCAATACCGAGCTGCGCGACATCGTT
CCGATTGACGGCAAGAAGGGCTATGACGTGCGCGATGTCATTGCCAAGATCGTCGACTGG
GGTGACTACCTCGAGGTCAAGGCCGGCTATGCCACCAACCTCGTGACCGCCTTCGCCCGG
GTCAATGGTCGTTCGGTGGGCATCGTGGCCAATCAGCCTTCGGTGATGTCGGGTTGCCTC
GACATCAACGCCTCTGACAAGGCCGCCGAATTCGTGAATTTCTGCGATTCGTTCAACATC
CCGCTGGTGCAGCTGGTCGACGTGCCGGGCTTCCTGCCCGTGCAGCAGGAGTACGGCGGC
ATCATTCGCCATGGGCGCAAGATGCTGTACGCCTACTCCGAGGCCACCGTGCCGAAGATC
ACGTGTCTCGCAACGCCTACGGCGGCTCCTACCTGGCCATGTGCAACCGTGACCTTGGTG
CCGACGCCGTGTACGCCTGTGCCCAGCGCCGAGATTGCGGTGATGGGCGCCGAGGGTGCG
GCAAATGTGATCTTCCGCAAGGAGATCAAGGCTGCCGACGATCCCGACGCCATGCGCGCC
GAGAAGATCGAGGAGTACCAGAACGGTTCAACACGCCGTACGTGGCGCGCCCGCGGTCAG
GTCGACGACGTGATTGACCCGGCTGATACCCGTCGAAAGATTGCTTCCGCCCTGGAGATG
TACGCCACCAAGCGTCAGACCCGCCCGGCGAAGAAGCCATGGAAACTTCCCCTGCTGAGC
GAGGAGGAAATTATGGCTGATGAGGAAGAGAAGGACCTGATGATCGCCACGCTCAACAAG
CGCGTCGCGTCATTGGAGTCTGAGTTGGGTTCACTCCAGAGCGATACCCAGGGTGTCACC
GAGGACGTACTGACGGCCATTTCGGCCGTTGCGGCCTATCTCGGCAACGATGGATCGGCT
GAGGTCGTCCATTTCGCCCCGAGCCCGAACTGGGTCCGCGAGGGTCGTCGGGCTCTGCAG
AACCATTCCATTCGTTGA

# Drug_Target_1_General_Function:
Involved in oxidoreductase activity

# Drug_Target_1_General_References:
8366018	Thornton CG, Kumar GK, Haase FC, Phillips NF, Woo SB, Park VM, Magner WJ, Shenoy BC, Wood HG, Samols D: Primary structure of the monomer of the 12S subunit of transcarboxylase as deduced from DNA and characterization of the product expressed in Escherichia coli. J Bacteriol. 1993 Sep;175(17):5301-8.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3240

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
65927

# Drug_Target_1_Name:
Methylmalonyl-CoA carboxyltransferase 12S subunit

# Drug_Target_1_Number_of_Residues:
611

# Drug_Target_1_PDB_ID:
1ON9

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01039	Carboxyl_trans

# Drug_Target_1_Protein_Sequence:
>Methylmalonyl-CoA carboxyltransferase 12S subunit
MAENNNLKLASTMEGRVEQLAEQRQVIEAGGGERRVEKQHSQGKQTARERLNNLLDPHSF
DEVGAFRKHRTTLFGMDKAVVPADGVVTGRGTILGRPVHAASQDFTVMGGSAGETQSTKV
VETMEQALLTGTPFLFFYDSGGARIQEGIDSLSGYGKMFFANVKLSGVVPQIAIIAGPCA
GGASYSPALTDFIIMTKKAHMFITGPQVIKSVTGEDVTADELGGAEAHMAISGNIHFVAE
DDDAAELIAKKLLSFLPQNNTEEASFVNPNNDVSPNTELRDIVPIDGKKGYDVRDVIAKI
VDWGDYLEVKAGYATNLVTAFARVNGRSVGIVANQPSVMSGCLDINASDKAAEFVNFCDS
FNIPLVQLVDVPGFLPGVQQEYGGIIRHGAKMLYAYSEATVPKITVVLRKAYGGSYLAMC
NRDLGADAVYAWPSAEIAVMGAEGAANVIFRKEIKAADDPDAMRAEKIEEYQNAFNTPYV
AAARGQVDDVIDPADTRRKIASALEMYATKRQTRPAKKPWKLPLLSEEEIMADEEEKDLM
IATLNKRVASLESELGSLQSDTQGVTEDVLTAISAVAAYLGNDGSAEVVHFAPSPNWVRE
GRRALQNHSIR

# Drug_Target_1_Reaction:
(S)-methylmalonyl-CoA + pyruvate = propanoyl-CoA + oxaloacetate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
The 12S subunit specifically catalyzes the transfer of the carboxyl group of methylmalonyl CoA to the biotin of the 1.3S subunit forming propanoyl-CoA and carboxylated 1.3S-biotin

# Drug_Target_1_SwissProt_ID:
Q8GBW6

# Drug_Target_1_SwissProt_Name:
12S_PROFR

# Drug_Target_1_Synonyms:
EC 2.1.3.1
Transcarboxylase 12S subunit

# Drug_Target_1_Theoretical_pI:
4.86

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04183
